Caffeine and the Risk of Diabetic Retinopathy in Type 2 Diabetes Mellitus: Findings from Clinical and Experimental Studies
Authors:
- Nuria AlcubierreNANuria Alcubierre
- Minerva Granado-CasasMGMinerva Granado-Casas
- Patricia BogdanovPBPatricia Bogdanov
- Cristina HernándezCHCristina Hernández
- Hugo RamosHRHugo Ramos
- Esmeralda CastelblancoECEsmeralda Castelblanco
- Jordi RealJRJordi Real
- Esther Rubinat-ArnaldoEREsther Rubinat-Arnaldo
- Alicia TravesetATAlicia Traveset
- Marta HernándezMHMarta Hernández
- Carmen JurjoCJCarmen Jurjo
- Jesús VioqueJesús Vioque
Open Access
Abstract
The aim of this study was to assess the potential benefits of caffeine intake in protecting against the development of diabetic retinopathy (DR) in subjects with type 2 diabetes (T2D). Furthermore, we tested the effect of topical administration of caffeine on the early stages of DR in an experimental model of DR. In the cross-sectional study, a total of 144 subjects with DR and 147 individuals without DR were assessed. DR was assessed by an experienced ophthalmologist. A validated food frequency questionnaire (FFQ) was administered. In the experimental model, a total of 20 mice were included. One drop (5 μL) of caffeine (5 mg/mL) (n = 10) or vehicle (5 μL PBS, pH 7.4) (n = 10) was randomly administered directly onto the superior corneal surface twice daily for two weeks in each eye. Glial activation and retinal vascular permeability were assessed using standard methods. In the cross-sectional study in humans, the adjusted-multivariable model showed that a moderate and high (Q2 and Q4) caffeine intake had a protective effect of DR (odds ratio (95% confidence interval) = 0.35 (0.16–0.78); p = 0.011 and 0.35 (0.16–0.77); p = 0.010, respectively). In the experimental model, the administration of caffeine did not improve either reactive gliosis or retinal vascular permeability. Our results suggest a dose-dependent protective effect of caffeine in the development of DR, while the potential benefits of antioxidants in coffee and tea should also be considered. Further research is needed to establish the benefits and mechanisms of caffeinated beverages in the development of DR.Keywords
Funding Information
- Instituto de Salud Carlos III (PS09/01035, FI11/0008, FPU15/03005)
- Instituto de Salud Carlos III (PS09/01035, FI11/0008, FPU15/03005)
- Ministerio de Educación, Cultura y Deporte (PS09/01035, FI11/0008, FPU15/03005)
This publication has 32 references indexed in Scilit:
- Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetesThe American Journal of Clinical Nutrition, 2013
- Reproducibility and validity of a food frequency questionnaire among pregnant women in a Mediterranean areaNutrition Journal, 2013
- Green Tea Is Neuroprotective in Diabetic RetinopathyInvestigative Ophthalmology & Visual Science, 2013
- Chlorogenic Acid Decreases Retinal Vascular Hyperpermeability in Diabetic Rat ModelJournal of Korean Medical Science, 2013
- The effect of caffeine on retinal vessel diameter in young healthy subjectsActa Ophthalmologica, 2012
- Glial and endothelial blood-retinal barrier responses to amyloid-β in the neural retina of the ratClinical Ophthalmology, 2008
- Coffee Consumption and Risk of Type 2 DiabetesJAMA, 2005
- Causal Relationship2004
- Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scalesOphthalmology, 2003
- Definition and prevalence of sedentarism in an urban population.American Journal of Public Health, 1999